Terms: = Endocrine gland cancer AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB AND Prognosis
4 results:
1. The expression of versican and its role in pancreatic neuroendocrine tumors.
Gao H; Cheng Y; Chen Y; Luo F; Shao Y; Sun Z; Bai C
Pancreatology; 2020 Jan; 20(1):142-147. PubMed ID: 31771905
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].
Tao T; Yang JX; Shen K; Cao DY
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):20-25. PubMed ID: 28190311
[No Abstract] [Full Text] [Related]
3. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ercc3-MYC Interactions as a Target in Pancreatic cancer.
Beglyarova N; Banina E; Zhou Y; Mukhamadeeva R; Andrianov G; Bobrov E; Lysenko E; Skobeleva N; Gabitova L; Restifo D; Pressman M; Serebriiskii IG; Hoffman JP; Paz K; Behrens D; Khazak V; Jablonski SA; Golemis EA; Weiner LM; Astsaturov I
Clin Cancer Res; 2016 Dec; 22(24):6153-6163. PubMed ID: 27384421
[TBL] [Abstract] [Full Text] [Related]
4. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
[TBL] [Abstract] [Full Text] [Related]
